Cargando…

Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience

Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel necrotizing vasculitis with multiple organ involvement. Despite improvements in clinical management, biomarkers for organ involvement and disease prognosis are still an unmet need. Methods: EGPA patients referred to o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matucci, Andrea, Vivarelli, Emanuele, Perlato, Margherita, Mecheri, Valentina, Accinno, Matteo, Cosmi, Lorenzo, Parronchi, Paola, Rossi, Oliviero, Vultaggio, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687644/ https://www.ncbi.nlm.nih.gov/pubmed/36359208 http://dx.doi.org/10.3390/biomedicines10112688

Ejemplares similares

EGPA Phenotyping: Not Only ANCA, but Also Eosinophils
por: Matucci, Andrea, et al.
Publicado: (2023)

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
por: Oiwa, Hiroshi, et al.
Publicado: (2017)

Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review
por: Banini, Marco, et al.
Publicado: (2023)

Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
por: Niccolai, Elena, et al.
Publicado: (2022)

Eosinophilic Granulomatosis with Polyangiitis (EGPA): A case report with atypical presentation
por: Mahmood, Khalid, et al.
Publicado: (2023)

Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma
por: Esposito, Ilaria, et al.
Publicado: (2023)

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
por: Celebi Sozener, Zeynep, et al.
Publicado: (2018)

Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis
por: Di Pietro, Linda, et al.
Publicado: (2023)

Eosinophilic Granulomatosis with Polyangiitis (EGPA) with an Unusual Manifestation of Mid-Ventricular Obstruction Caused by Endocardial Thrombus
por: Ito, Takahide, et al.
Publicado: (2018)

Destructive Upper Airway Disease from Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Very First Case
por: Saha, Biplab, et al.
Publicado: (2019)

Eosinophilic granulomatosis with polyangiitis (EGPA) with low activity EBV replication during the COVID 19 pandemic
por: Mueller, Melina, et al.
Publicado: (2022)

Coronary Artery Dissection and Myocarditis Caused by Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Case Report
por: Vivek, Vidhyalakshmy, et al.
Publicado: (2023)

ANCA negative eosinophilic granulomatosis with polyangiitis (EGPA) presenting with left ventricular thrombus: An appreciation of distinct phenotypes and eosinophilic driven pathogenesis
por: Chaivannacoopt, Kai, et al.
Publicado: (2022)

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Eosinophilic Granulomatosis Polyangiitis (EGPA) Masquerading as a Mycotic Aneurysm of the Abdominal Aorta: Case Report and Review of Literature
por: Kumari, Pooja, et al.
Publicado: (2021)

Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients
por: Bell, Christopher F, et al.
Publicado: (2023)

A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies
por: Yousuf, Kauser, et al.
Publicado: (2023)

Case Report: Severe Eosinophilic Asthma Associated With ANCA-Negative EGPA in a Young Adult Successfully Treated With Benralizumab
por: Ricciardi, Luisa, et al.
Publicado: (2022)

Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature
por: Kai, Martine, et al.
Publicado: (2023)

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
por: Matucci, Andrea, et al.
Publicado: (2018)

Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment
por: Assmann, Gunter, et al.
Publicado: (2014)

The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion
por: Milne, Megan E., et al.
Publicado: (2022)

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)

Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease
por: Shrestha, Pragya, et al.
Publicado: (2020)

Mechanisms of Drug Desensitization: Not Only Mast Cells
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
por: Detoraki, Aikaterini, et al.
Publicado: (2021)

Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody
por: Isozaki, Takeo, et al.
Publicado: (2020)

Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19
por: Bruno, Chiara, et al.
Publicado: (2020)

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2017)

Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
por: Matucci, Andrea, et al.
Publicado: (2021)

A gendered magnifying glass on COVID-19
por: Salvati, Lorenzo, et al.
Publicado: (2020)

Is determining nasal eosinophil count and nasal eosinophil peroxidase concentration clinically useful in children with rhinits?
por: Choi, Bong Seok
Publicado: (2019)

Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

“A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics”
por: Demoly, Pascal, et al.
Publicado: (2016)

Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
por: Palterer, Boaz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9kc9tf4leo7qqqrjj66ge1nhut